• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.71% Nasdaq Down1.12%

    More On DYAI



    News & Info


    Analyst Coverage



    Dyadic International, Inc. (DYAI)

    -Other OTC
    0.97 Down 0.01(1.02%) 2:39PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Dyadic International, Inc.
    140 Intracoastal Pointe Drive
    Suite 404
    Jupiter, FL 33477
    United States - Map
    Phone: 561-743-8333
    Fax: 561-743-8343
    Website: http://www.dyadic.com

    Index Membership:N/A
    Full Time Employees:57

    Business Summary 

    Dyadic International, Inc., a biotechnology company, discovers, develops, manufactures, and sells enzymes and other proteins for the bioenergy, biochemical, biopharmaceutical, and industrial enzyme industries. It utilizes an integrated technology platform based on its patented and proprietary C1 microorganism, which enables the development and manufacture of enzymes and other proteins for various markets. The company licenses its patented and proprietary technologies; and provides research and development services for third parties. In addition, it manufactures and sells liquid and dry enzyme products for use in the animal feed, pulp and paper, starch and alcohol, food and brewing, textiles, and biofuels industries. The company’s C1 Platform Technology could also be used for developing and producing other biological products, such as antibodies, vaccines, proteins, and polypeptides for the biopharmaceutical industry. Dyadic International, Inc. has operations in the United States and the Netherlands. The company was founded in 1979 and is headquartered in Jupiter, Florida.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Dyadic International, Inc.

    Key Executives 
    Mr. Mark A. Emalfarb , 60
    Chief Exec. Officer, Pres, Founder, Director and Chairman of Nominating Committee
    Mr. Danai Eric Brooks , 38
    Chief Operating Officer and Exec. VP
    Mr. Richard H. Jundzil , 43
    VP of Operations
    Mr. Thomas L. Dubinski , 59
    Chief Financial Officer and VP
    Dr. Wim Van Der Wilden , 65
    Gen. Mang. of Dyadic Netherlands
    Dr. Ronen Tchelet Ph.D.,
    VP of Bus. Devel. for Europe
    Amounts are as of Dec 31, 2006 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.